Peripheral alpha-synuclein and Parkinson's disease

Movement Disorders

Volumn 29, Issue 8, 2014, Pages 963-966

  Olanow, C Warren ^a   Wakeman, Dustin R ^b   Kordower, Jeffrey H ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE TRANSPORTER; PEPTIDOGLYCAN RECOGNITION PROTEIN;

BRAIN STEM; DIFFUSE LEWY BODY DISEASE; DOPAMINERGIC NERVE CELL; EARLY DIAGNOSIS; EDITORIAL; GASTROINTESTINAL INFECTION; HUMAN; INTESTINE FLORA; MOTOR DYSFUNCTION; NERVE CELL DEGENERATION; PARASOMNIA; PARKINSON DISEASE; PRIORITY JOURNAL; ANIMAL; METABOLISM; PATHOLOGY;

ALPHA-SYNUCLEIN; ANIMALS; HUMANS; PARKINSON DISEASE;

EID: 84904394120     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25966     Document Type: Editorial

References (22)

1. Olanow CW, Prusiner SB. Is Parkinson's disease a prion disorder. Proc Natl Acad Sci 2009;106:12571-12572.
2. Olanow CW, Brundin P. Alpha synuclein, prions, and Parkinson's Disease. Movement Disorders 2013; 28: 31-40.
3. Braak H, Del Tredici K, Rüb U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003 Mar-Apr 24(2):197-211.
4. Kordower JH, Olanow CW, Dodiya HB, et al. Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. Brain 2013; 136: 2419-2431.
5. Beach TG, Adler CH, Sue LI, et al. Arizona Parkinson's Disease Consortium. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol. 2010 Jun;119(6):689-702.
6. Shannon KM, Keshavarzian A, Mutlu E, et al. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease. Mov Disord. 2012 May;27(6):709-15.
7. Pouclet H, Lebouvier T, Coron E, et al. Lewy pathology in gastric and duodenal biopsies in Parkinson's Disease. Mov Disord. 2012;27:708.
8. Braak H, de Vos RA, Bohl J, et al. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett. 2006;396:67-72.
9. Shannon KM, Keshavarzian A, Dodiya HB, et al. Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases. Mov Disord. 2012;27:716-9.
10. Iranzo A, Gelpi E, Tolosa E, et al. Neuropathology of prodromal Lewy body disease. Mov Disord. 2014;29:410-5.
11. Berg D, Postuma RB, Bloem B, et al. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Mov Disord. 2014;29:454-62.
12. Gelpi E, Navarro-Otano J, Tolosa E, et al. Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders. Mov Disord. 2014;29:1010-8.
13. Gray MT, Munoz DG, Gray DA et al. α-synuclein in the appendiceal mucosa of neurologically intact subjects. Mov Disord. 2013 Dec 18.
14. Derkinderen P, Shannon K, Brundin P. Gut feelings about smoking and coffee in Parkinson's disease. Mov Disord. 2014;29:976-9.
15. Biedermann L, Zeitz J, Mwinyi J, et al. Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans. PLoS One 2013;8:e59260.
16. Devos D, Lebouvier T, Lardeux B, et al. Colonic inflammation in Parkinson's disease. Neurobiol Dis 2013;50:42-48.
17. Hilton D, Stephens M, Kirk L, et al. Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease. Acta Neuropathol. 2014;127:235-41.
18. Forsyth CB, Shannon KM, Kordower JH, et al. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease. PLoS One. 2011;6:e28032.
19. Goldman SM, Kamel F, Ross GW, et al. Peptidoglycan recognition protein genes and risk of Parkinson's disease. Mov Disord. 2014 (in press).
20. Kelly LP, Carvey PM, Keshavarzian A, et al. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease. Mov Disord. 2013 Nov 4.
21. Hallett PJ, McLean JR, Kartunen A, Langston JW, Isacson O. α-Synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficits. Neurobiol Dis. 2012;47:258-67.
22. Ulusoy A, Rusconi R, Pérez-Revuelta BI, et al. Caudo-rostral brain spreading of α-synuclein through vagal connections. EMBO Mol Med. 2013 Jul;5(7):1051-9.